With our strong R&D and platform technologies, we seek value-added collaborations with academic and corporate partners across therapeutic areas for our HBV cure and Microbiome platforms.

Assembly entered into a collaboration and license agreement with Allergan to jointly develop our microbiome assets for IBD, IBS and other microbiome-related GI indications.

Allergan logo Image

If your organization is interested in collaborating with Assembly please contact BD@assemblybio.com.